Recombinant Human Insulins – Clinical Efficacy and Safety in Diabetes Therapy
Open Access
- 1 January 2016
- journal article
- review article
- Published by Touch Medical Media, Ltd. in touchREVIEWS in Endocrinology
- Vol. 12 (1), 12-17
- https://doi.org/10.17925/EE.2016.12.01.12
Abstract
Insulin replacement therapy is the standard of care for patients with type 1 and advanced type 2 diabetes mellitus. Porcine and bovine pancreatic tissue was the source of the hormone for many years, followed by semisynthetic human insulin obtained by modification of animal insulin. With the development of recombinant DNA technology, recombinant (biosynthetic) human insulin became available in large amounts by biosynthesis in microorganisms (Escherichia coli, yeast) providing reliable supplies of the hormone worldwide at affordable costs. The purity and pharmaceutical quality of recombinant human insulin was demonstrated to be superior to animal and semisynthetic insulin and patients with diabetes could be safely and effectively transferred from animal or semisynthetic human insulin to recombinant human insulin with no change expected in insulin dose. The decision for change remains a clinical objective, follow-up after any change of insulin product is recommended to confirm clinical efficacy. This review provides a summary and retrospective assessment of early clinical studies with recombinant insulins (Insuman®, Humulin®, Novolin®).Keywords
This publication has 46 references indexed in Scilit:
- Stepwise intensification of insulin therapy in Type 2 diabetes management—exploring the concept of the basal‐plus approach in clinical practiceDiabetic Medicine, 2013
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered ApproachDiabetes Care, 2012
- Forum for injection techniques, India: The first Indian recommendations for best practice in insulin injection techniqueIndian Journal of Endocrinology and Metabolism, 2012
- Hypoglycemia in Type 1 Diabetes MellitusEndocrinology and Metabolism Clinics of North America, 2010
- Insulin for type 2 diabetes: choosing a second-line insulin regimenInternational Journal of Clinical Practice, 2008
- Managing Preexisting Diabetes for PregnancyDiabetes Care, 2008
- External and implantable insulin pumps: current place in the treatment of diabetesExperimental and Clinical Endocrinology & Diabetes, 2001
- Changing from Porcine to Human InsulinDrugs, 1994
- Human InsulinDrugs, 1987
- A Comparison of Semisynthetic Human NPH Insulin and Porcine NPH Insulin in the Treatment of Insulin‐dependent Diabetes MellitusDiabetic Medicine, 1987